140 related articles for article (PubMed ID: 11293392)
21. Drug treatment of combined hyperlipidemia.
Wierzbicki AS; Mikhailidis DP; Wray R
Am J Cardiovasc Drugs; 2001; 1(5):327-36. PubMed ID: 14728015
[TBL] [Abstract][Full Text] [Related]
22. [Part II. Combination statin plus fibrate regimens (free and fixed)].
Clin Investig Arterioscler; 2016 Jul; 28 Suppl 3():11-9. PubMed ID: 27473466
[No Abstract] [Full Text] [Related]
23. The effect of fibrate-statin combination therapy on cardiovascular events: a retrospective cohort analysis.
Wierzbicki AS; Morrell J; Hemsley D; McMahon Z; Crook MA; Wray R
Curr Med Res Opin; 2010 Sep; 26(9):2141-6. PubMed ID: 20662558
[TBL] [Abstract][Full Text] [Related]
24. [Which statin is more efficient? Concepts and applications in economic evaluation].
García-Altés A; Jovell AJ
Aten Primaria; 2000 Sep; 26(5):333-8. PubMed ID: 11100606
[No Abstract] [Full Text] [Related]
25. [The fixed combination of pravastatin and fenofibrate: what can it provide?].
Díaz Rodríguez Á
Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():12-6. PubMed ID: 25043541
[TBL] [Abstract][Full Text] [Related]
26. Statin-fibrate combination for mixed dyslipidaemia: a limited option?
Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
Curr Med Res Opin; 2010 Sep; 26(9):2137-40. PubMed ID: 20662560
[TBL] [Abstract][Full Text] [Related]
27. Combination drug therapy for familial combined hyperlipidemia.
East C; Bilheimer DW; Grundy SM
Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis of safety of the coadministration of statin with fenofibrate in patients with combined hyperlipidemia.
Guo J; Meng F; Ma N; Li C; Ding Z; Wang H; Hou R; Qin Y
Am J Cardiol; 2012 Nov; 110(9):1296-301. PubMed ID: 22840347
[TBL] [Abstract][Full Text] [Related]
29. [Rhabdomyolysis secondary to simvastatin and phenofibrate].
Forcadell-Peris MJ; de Diego-Cabanes C
Semergen; 2014; 40(4):e91-4. PubMed ID: 24768027
[TBL] [Abstract][Full Text] [Related]
30. Atorvastatin monotherapy vs. combination therapy in the management of patients with combined hyperlipidemia.
Avisar I; Brook JG; Wolfovitz E
Eur J Intern Med; 2008 May; 19(3):203-8. PubMed ID: 18395165
[TBL] [Abstract][Full Text] [Related]
31. Combination therapy with HMG CoA reductase inhibitors and gemfibrozil: practical or perilous?
Duell PB; Illingworth DR
Heart Dis Stroke; 1993; 2(3):260-2. PubMed ID: 8137035
[No Abstract] [Full Text] [Related]
32. Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy.
Pogson GW; Kindred LH; Carper BG
Am J Cardiol; 1999 Apr; 83(7):1146. PubMed ID: 10190540
[No Abstract] [Full Text] [Related]
33. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
Bredie SJ; de Bruin TW; Demacker PN; Kastelein JJ; Stalenhoef AF
Am J Cardiol; 1995 Feb; 75(5):348-53. PubMed ID: 7856526
[TBL] [Abstract][Full Text] [Related]
34. Statin-fibrate combination therapy.
Shek A; Ferrill MJ
Ann Pharmacother; 2001; 35(7-8):908-17. PubMed ID: 11485144
[TBL] [Abstract][Full Text] [Related]
35. Long-term safety of statin-fibrate combination treatment in the management of hypercholesterolaemia in patients with coronary artery disease.
Feher MD; Foxton J; Banks D; Lant AF; Wray R
Br Heart J; 1995 Jul; 74(1):14-7. PubMed ID: 7662446
[TBL] [Abstract][Full Text] [Related]
36. Physician variation in the de-adoption of ineffective statin and fibrate therapy.
Everhart A; Desai NR; Dowd B; Herrin J; Higuera L; Jeffery MM; Jena AB; Ross JS; Shah ND; Smith LB; Karaca-Mandic P
Health Serv Res; 2021 Oct; 56(5):919-931. PubMed ID: 33569804
[TBL] [Abstract][Full Text] [Related]
37. Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice.
Choudhry NK; Levin R; Winkelmayer WC
Heart; 2007 Aug; 93(8):945-51. PubMed ID: 17344334
[TBL] [Abstract][Full Text] [Related]
38. A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin.
Nestel P; Simons L; Barter P; Clifton P; Colquhoun D; Hamilton-Craig I; Sikaris K; Sullivan D
Atherosclerosis; 1997 Mar; 129(2):231-9. PubMed ID: 9105566
[TBL] [Abstract][Full Text] [Related]
39. [Drug-induced myopathies].
Ando H; Fujimura A
Nihon Rinsho; 2007 Oct; 65 Suppl 8():390-3. PubMed ID: 18074569
[No Abstract] [Full Text] [Related]
40. Effectiveness of high doses of simvastatin as monotherapy in mixed hyperlipidemia.
Miller M; Dolinar C; Cromwell W; Otvos JD
Am J Cardiol; 2001 Jan; 87(2):232-4, A9. PubMed ID: 11152850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]